[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622251":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":43,"collaborators":45,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":10,"eligibilityCriteria":70,"healthyVolunteers":71,"sex":72,"minAge":73,"maxAge":10,"enrollmentInfo":74,"targetDuration":77,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Qilu Hospital of Shandong University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients undergoing EUS",null,"Patients aged ≥18 years scheduled for EUS with suspected solid pancreatic lesions based on clinical symptoms, medical history, laboratory tests or radiological examinations agree to participate in the research and be able to sign informed consent.",[13],"Device: iEUS-SPL(intelligent endoscopic ultrasound system-pancreatic solid lesion)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","iEUS-SPL(intelligent endoscopic ultrasound system-pancreatic solid lesion)","The iEUS-SPL will automaticly detect solid pancreatic lesions and integrate the patients' endoscopic ultrasound images, endoscopic ultrasound features, clinical data and imaging features to perform a five-category classification for the lesions, categorizing them as pancreatic cancer, pancreatic neuroendocrine tumor, solid pseudopapillary tumor, autoimmune pancreatitis and chronic pancreatitis.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Zhen Li","CONTACT","18560086106","qilulizhen@sdu.edu.cn",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Jinan","Shandong","250012","China","CN",{"type":35,"coordinates":36},"Point",[37,38],116.99722,36.66833,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":24,"phoneExt":10,"email":25},"Zhen Li, doctor",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46,48,50,52,54,57,59,61,63],{"name":47,"class":6},"Liaocheng People's Hospital",{"name":49,"class":6},"Taian City Central Hospital",{"name":51,"class":6},"Qilu Hospital of Shandong University (Qingdao)",{"name":53,"class":6},"Binzhou People's Hospital",{"name":55,"class":56},"Shandong Provincial Hospital","OTHER_GOV",{"name":58,"class":6},"The Affiliated Hospital of Qingdao University",{"name":60,"class":6},"Qianfoshan Hospital",{"name":62,"class":6},"Shengli Oilfield Hospital",{"name":64,"class":6},"Binzhou Medical University","100622251","an-artificial-intelligence-system-for-multimodal-multi-class-diagnosing-solid-pancreatic-lesions-based-on-endoscopic-ultrasound-100622251",false,"NCT07381192","An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound","Inclusion Criteria:\n\n1. Patients aged ≥18 years scheduled for EUS with suspected solid pancreatic lesions based on clinical symptoms, medical history, laboratory tests or radiological examinations agree to participate in the research and be able to sign informed consent.\n2. Patients with no prior history of treatment for pancreatic lesions.\n\nExclusion Criteria:\n\n1. Patients with absolute contraindications to EUS examination.\n2. Pregnancy or lactating.\n3. Uncorrectable coagulopathy(PTT\\>50 seconds or INR\\>1.5) and\u002For uncorrectable thrombocytopenia(platelet count\\\u003C50×109\u002FL).\n4. Upper gastrointestinal obstruction.\n5. Patients who underwent surgical treatment or anatomical alterations of the pancreas due to lesions in other thoracic and\u002For abdominal organs, as well as patients with congenital anatomical abnormalities.\n6. Patients who have undergone biliary\u002Fpancreatic duct stent placement.\n7. Patients who refuse to sign the informed consent.",true,"ALL","18 Years",{"count":75,"type":76},383,"ESTIMATED","6 Months","OBSERVATIONAL","The aim of this study is to validate an artificial intelligence system named iEUS-SPL(intelligent endoscopic ultrasound system-solid pancreatic lesion) for detecting and multimodal, multi-class diagnosing solid pancreatic lesions during endoscopic ultrasound(EUS) examination.",[81,82],"Endoscopic Ultrasound (EUS)","Solid Pancreatic Lesion",[84,85],"endoscopic ultrasound","solid pancreatic lesion","2026-01-23",{"date":88,"type":89},"2026-02-02","ACTUAL",{"date":91,"type":89},"2025-09-01",{"date":93,"type":76},"2028-06-30",{"name":5,"class":6},1]